Literature DB >> 23355430

MRI of ovarian masses.

Hebert Alberto Vargas1, Tristan Barrett, Evis Sala.   

Abstract

MRI provides exquisite views of the pelvic anatomy through its high spatial resolution and tissue contrast, and as such plays a key role in the work up of ovarian lesions, identifying features that distinguish benign and malignant lesions. In the case of primary tumors it enables local staging and detection of metastatic disease to help guide management options such as complex surgery or the consideration of neoadjuvant chemotherapy. Functional MRI techniques such as diffusion-weighted MRI (DW-MRI), dynamic contrast-enhanced MRI (DCE-MRI) and tumor-selective molecular imaging are currently being evaluated as possible predictive and prognostic biomarkers in the context of ovarian malignancy, and may play a larger role in routine clinical practice in the future. Herein we provide an overview of the conventional and advanced MRI techniques used to characterize ovarian masses and of the role that MR plays in the staging, treatment selection and follow up of patients with ovarian cancer.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355430     DOI: 10.1002/jmri.23721

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  12 in total

1.  Do DWI and quantitative DCE perfusion MR have a prognostic value in high-grade serous ovarian cancer?

Authors:  Francesca De Piano; Valentina Buscarino; Dulia Maresca; Patrick Maisonneuve; Giovanni Aletti; Roberta Lazzari; Andrea Vavassori; Massimo Bellomi; Stefania Rizzo
Journal:  Radiol Med       Date:  2019-08-31       Impact factor: 3.469

2.  Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors.

Authors:  Xinhua Fan; Hongbin Zhang; Shuang Meng; Jing Zhang; Chuge Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 3.  O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.

Authors:  Elizabeth A Sadowski; Isabelle Thomassin-Naggara; Andrea Rockall; Katherine E Maturen; Rosemarie Forstner; Priyanka Jha; Stephanie Nougaret; Evan S Siegelman; Caroline Reinhold
Journal:  Radiology       Date:  2022-01-18       Impact factor: 11.105

4.  Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.

Authors:  Ximing Zhang; Min Li; Zhuopeng Tang; Xinyi Li; Ting Song
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

5.  Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model.

Authors:  Meltem Ocak; Andrea G Gillman; Jamee Bresee; Lixin Zhang; Anda M Vlad; Cristina Müller; Roger Schibli; W Barry Edwards; Carolyn J Anderson; H Michael Gach
Journal:  Mol Pharm       Date:  2015-01-14       Impact factor: 4.939

6.  MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity.

Authors:  J Cebulla; E M Huuse; K Pettersen; A van der Veen; E Kim; S Andersen; W S Prestvik; A M Bofin; A P Pathak; G Bjørkøy; T F Bathen; S A Moestue
Journal:  Br J Cancer       Date:  2014-12-23       Impact factor: 7.640

7.  Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.

Authors:  Auni Lindgren; Maarit Anttila; Suvi Rautiainen; Otso Arponen; Annukka Kivelä; Petri Mäkinen; Kirsi Härmä; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Ylä-Herttuala; Ritva Vanninen; Hanna Sallinen
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

8.  The diagnostic value of magnetic resonance imaging in differentiating benign and malignant pediatric ovarian tumors.

Authors:  Carlijn L Janssen; Annemieke S Littooij; Marta Fiocco; Josephine C B Huige; Ronald R de Krijger; Caroline C C Hulsker; Angelique J Goverde; József Zsiros; Annelies M C Mavinkurve-Groothuis
Journal:  Pediatr Radiol       Date:  2020-11-13

9.  Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.

Authors:  Hye-Yon Cho; Min Sun Kyung
Journal:  Med Sci Monit       Date:  2014-07-30

10.  MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.

Authors:  Lotte W E van Nimwegen; Annelies M C Mavinkurve-Groothuis; Ronald R de Krijger; Caroline C C Hulsker; Angelique J Goverde; József Zsiros; Annemieke S Littooij
Journal:  Eur Radiol       Date:  2019-09-16       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.